NeueHealth Dirección

Dirección controles de criterios 2/4

El CEO de NeueHealth's es Mike Mikan , nombrado en Jan 2019, tiene una permanencia de 5.25 años. compensación anual total es $9.90M, compuesta por 13.1% salario y 86.9% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.81% de las acciones de la empresa, por valor de $410.68K. La antigüedad media del equipo directivo y de la junta directiva es de 1.5 años y 4.7 años, respectivamente.

Información clave

Mike Mikan

Chief Executive Officer (CEO)

US$9.9m

Compensación total

Porcentaje del salario del CEO	13.1%
Permanencia del CEO	5.3yrs
Participación del CEO	0.8%
Permanencia media de la dirección	1.6yrs
Promedio de permanencia en la Junta Directiva	4.8yrs

Actualizaciones recientes de la dirección

Recent updates

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Oct 11

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Aug 13

Bright Health Group Takes Cost Actions To Effect Turnaround

Jul 21

Bright Health Group: Examining A Dumpster Fire

Jan 04

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mike Mikan en comparación con los beneficios de NeueHealth?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-US$510m
Dec 31 2023	US$10m	US$1m	-US$563m
Sep 30 2023	n/a	n/a	-US$1b
Jun 30 2023	n/a	n/a	-US$660m
Mar 31 2023	n/a	n/a	-US$700m
Dec 31 2022	US$10m	US$1m	-US$521m
Sep 30 2022	n/a	n/a	-US$373m
Jun 30 2022	n/a	n/a	-US$513m
Mar 31 2022	n/a	n/a	-US$450m
Dec 31 2021	US$181m	US$1m	-US$330m
Sep 30 2021	n/a	n/a	-US$534m
Jun 30 2021	n/a	n/a	-US$293m
Mar 31 2021	n/a	n/a	-US$266m
Dec 31 2020	US$5m	US$600k	-US$161m

Compensación vs. Mercado: La compensación total de Mike($USD9.90M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD668.06K).

Compensación vs. Ingresos: La compensación de Mike ha sido consistente con los resultados de la empresa en el último año.

CEO

Mike Mikan (51 yo)

5.3yrs

Permanencia

US$9,898,059

Compensación

Mr. George Lawrence Mikan, III, also known as Mike, is Chief Executive Officer at NeueHealth, Inc. (formerly known as Bright Health Group, Inc.) (formerly Bright Health, Inc) since April 2020 and its Presi...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Robert Sheehy	Co-Founder & Chairman	9.3yrs	sin datos	3.12% $ 1.5m
George Mikan	Vice Chairman	5.3yrs	US$9.90m	0.81% $ 393.5k
Jay Matushak	Chief Financial Officer	less than a year	US$1.77m	0.11% $ 52.5k
Tomas Orozco	Executive Vice President of Consumer Care	less than a year	US$1.59m	0.063% $ 30.9k
Jeffrey Scherman	Chief Accounting Officer	no data	sin datos	0.043% $ 20.9k
Jeff Craig	General Counsel & Corporate Secretary	2.2yrs	US$832.55k	0.043% $ 20.8k
Stacy Conti	Chief People Officer	no data	sin datos	sin datos
Joaquin Baralt	President of Value-Based Care	no data	sin datos	sin datos

1.6yrs

Permanencia media

48yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de NEUE no se considera experimentado ( 1.5 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Robert Sheehy	Co-Founder & Chairman	9.3yrs	sin datos	3.12% $ 1.5m
George Mikan	Vice Chairman	5.3yrs	US$9.90m	0.81% $ 393.5k
Andrew Slavitt	Independent Director	2.8yrs	US$153.68k	0.20% $ 98.6k
Jeffrey Immelt	Independent Director	4.1yrs	US$173.68k	0.11% $ 52.6k
Mohamad Makhzoumi	Independent Director	8.2yrs	US$163.68k	sin datos
Linda Gooden	Independent Director	5.3yrs	US$163.68k	0.015% $ 7.2k
Manuel Kadre	Independent Lead Director	3.5yrs	US$188.68k	0.23% $ 110.8k
Stephen H. Kraus	Independent Director	8.2yrs	US$163.68k	0.015% $ 7.2k
Matthew Manders	Independent Director	2.2yrs	US$153.68k	0.019% $ 9.0k
Kedrick Adkins	Independent Director	4.3yrs	US$178.68k	0.015% $ 7.2k

4.8yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de NEUE se considera experimentada (4.7 años de antigüedad promedio).

NeueHealth Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

NeueHealth, Inc., Annual General Meeting, May 02, 2024

Vice Chairman recently sold US$59k worth of stock

Bright Health Group, Inc. Announces Leaving of Jeff Cook as Chief Operating Officer, Effective October 13, 2023

Bright Health Group Announces Chief Financial Officer Changes

Vice Chairman recently sold US$158k worth of stock

Independent Director recently bought US$248k worth of stock

Recent updates

NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024

First quarter 2024 earnings released: US$2.31 loss per share (vs US$9.04 loss in 1Q 2023)

NeueHealth, Inc. to Report Q1, 2024 Results on May 08, 2024

NeueHealth, Inc., Annual General Meeting, May 02, 2024

Vice Chairman recently sold US$59k worth of stock

New minor risk - Shareholder dilution

New major risk - Negative shareholders equity

Full year 2023 earnings released: US$70.72 loss per share (vs US$98.28 loss in FY 2022)

NeueHealth, Inc. Provides Earnings Guidance for the Year 2024

NeueHealth, Inc. to Report Q4, 2023 Results on Mar 06, 2024

Third quarter 2023 earnings released: US$72.52 loss per share (vs US$40.11 loss in 3Q 2022)

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

New major risk - Revenue and earnings growth

Bright Health Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Bright Health Group, Inc. Announces Leaving of Jeff Cook as Chief Operating Officer, Effective October 13, 2023

Consensus EPS estimates upgraded to US$51.32 loss

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Revises Its Financial Outlook for 2023

Bright Health Group, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Price target increased by 47% to US$200

Florence Labs, Inc. acquired Zipnosis, Inc. from Bright Health Group, Inc. (NYSE:BHG).

Price target decreased by 14% to US$1.70

Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Bright Health Group Announces Chief Financial Officer Changes

Vice Chairman recently sold US$158k worth of stock

Price target decreased by 24% to US$1.50

Consensus EPS estimates fall by 14%

Full year 2022 earnings released: US$1.23 loss per share (vs US$3.02 loss in FY 2021)

Bright Health Group, Inc. to Report Q4, 2022 Results on Mar 01, 2023

Bright Health Group: Stock Price Has Been Too Heavily Beaten Down

Bright Health Group expects FY23 revenue to be below consensus

Independent Director recently bought US$248k worth of stock

Bright Health Group Receives Continued Listing Standard Notice from NYSE

Bright Health receives non-compliance notice from NYSE

Independent Lead Director recently bought US$294k worth of stock

Price target decreased to US$2.07

High number of new directors

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Reports Goodwill Impairment for the Three Months Ended September 30, 2022

Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance

Bright Health Group, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Bright Health Group, Inc. announced that it has received $175 million in funding from a group of investors

Bright Health Group, Inc. Provides Revenue Guidance for the Year 2023

Bright Health narrows footprint to only offer Medicare Advantage in California, Florida

Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Bright Health Group, Inc. Provides Revenue Guidance for the Full Year 2022

Bright Health Group, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Bright Health Group Takes Cost Actions To Effect Turnaround

Price target decreased to US$2.76

Bright Health Group, Inc.(NYSE:BHG) dropped from Russell 2000 Growth Index

Bright Health Group Expands Executive Team as It Drives Performance in Scaled Businesses

Consensus forecasts updated

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Bright Health Group, Inc. to Report Q1, 2022 Results on May 04, 2022

Bright Health Group, Inc., Annual General Meeting, May 13, 2022

Consensus forecasts updated

Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022

Bright Health Group, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Bright Health Group Announces Executive Changes, Effective March 11, 2022

Pomerantz LLP Files A Class Action Lawsuit Against Bright Health Group, Inc

Pomerantz LLP Files A Class Action Lawsuit Against Bright Health Group, Inc

Pomerantz Law Firm Announces the Filing of A Class Action Against Bright Health Group, Inc

Bright Health Group, Inc. announced that it has received $750 million in funding from CIGNA Health and Life Insurance Company, New Enterprise Associates, Inc.

Bright Health Group: Examining A Dumpster Fire